1,10-Decanediaminium,N1,N1,N1,N10,N10,N10-hexamethyl-, bromide (1:2) cas no:541-22-0

Name1,10-Decanediaminium,N1,N1,N1,N10,N10,N10-hexamethyl-, bromide (1:2)
CAS541-22-0
Synonyms1,10-Decanediaminium,N,N,N,N',N',N'-hexamethyl-, dibromide (9CI); Ammonium, decamethylenebis[trimethyl-bromide] (6CI); Ammonium, decamethylenebis[trimethyl-, dibromide (8CI); C 10; C10 (onium compound); Decacuran; Decamethonium bromide; Decamethonium dibromide;Decamethylene-1,10-bistrimethylammonium dibromide; Decamethylenebis[trimethylammoniumbromide]; Syncurine
EINECS(EC#)208-772-2
Molecular FormulaC16H38 N2 . 2 Br
Molecular Weight258.48632

Appearancecrystalline solid

Hazardclass6.1(b)

Hazard T
Risk R25;R36/37/38
Safety

Hazard Codes: T
Risk Statements: 25-36/37/38 
R25 :Toxic if swallowed. 
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-45 
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: UN 2811 6.1/PG 3
WGK Germany: 3
RTECS: BP5950000
F: 3-10
HazardClass: 6.1(b)
PackingGroup: III
Deadly poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. When heated to decomposition it emits very toxic fumes of NO_x, NH₃, and Br⁻. See also BROMIDES.

1.		ipr-rat LD50:2900 µg/kg		TXAPA9    Toxicology and Applied Pharmacology. 14 (1969),67.
2.		orl-mus LD50:190 mg/kg		JPETAB    Journal of Pharmacology and Experimental Therapeutics. 118 (1956),395.
3.		ipr-mus LD50:900 µg/kg		JAPMA8    Journal of the American Pharmaceutical Association, Scientific Edition. 45 (1956),792.
4.		scu-mus LD50:4 mg/kg		YKKZAJ    Yakugaku Zasshi. Journal of Pharmacy. 74 (1954),911.
5.		ivn-mus LD50:630 µg/kg		AIPTAK    Archives Internationales de Pharmacodynamie et de Therapie. 105 (1956),221.
6.		ivn-cat LD50:35 µg/kg		JPETAB    Journal of Pharmacology and Experimental Therapeutics. 118 (1956),395.
7.		ivn-rbt LD50:125 µg/kg		JPETAB    Journal of Pharmacology and Experimental Therapeutics. 118 (1956),395.